Company Profile / Sanofi Egypt: In It for the Long Haul
As one of the longest-standing multinational companies in Egypt, French pharmaceutical giant Sanofi aims to plays a…
MIDDLE EAST & AFRICA
UAE Accelerated Drug Approvals
The UAE ranks among the world’s fastest for new drug approvals, ranking first for two cancer drugs and second…
MEA / Saudi Arabia’s Bold Ambition to Become a Regional Pharma Hub
Saudi Arabia is aiming to become a more attractive investment destination for multinational pharma companies…
Pharma Faces / Paolo Carli, Merck MEAR
Paolo Carli, head of Middle East, Africa, Turkey, Russia and CIS (MEAR) for Merck has continually taken on greater…
UAE Pharma Growth Projection Snapshot
The UAE pharma market is projected to grow over 80 percent by 2027, in part due to a growing demand for the…
Drug Shortage / European Solutions to Algeria’s Medicine Supply Shortages
Yacine Sellam, president of the Algerian Society for Regulatory Affairs & Pharmacoeconomics, looks at how…
CEO Profile / Egypt's First Mover in Nutraceuticals
Dr Mohsen Shalaby of Nerhadou International explains how he built Egypt’s leading mineral supplement and…
Middle East / 3 Regulatory Trends Impacting UAE Healthcare
We look at three of the most important regulatory trends in UAE healthcare and the impact they stand to have on…
Generics / UAE Pharma’s First Steps into North America
LIFEPharma, a subsidiary of UAE-based VPS Healthcare, has signed a Dh 200 million (USD 55 million) deal with…
In Conversation
Interview: Hamouda Zaouia – Regional Manager Africa, Middle East and Turkey; Khaled Laouiti – General Manager Tunisia, Libya and sub-Saharan Africa, Pierre Fabre
Hamouda Zaouia, regional manager Africa, Middle East and Turkey, and Khaled Laouiti, general manager Tunisia, Libya and sub-Saharan Africa, stress the important strategic position the African continent has for Pierre Fabre. They describe the company’s approach when tailoring its portfolio to truly target the needs of patients and Pierre Fabre’s commitments to ensuring patient access to its medicines and the…
Latest Reports
Focus on Turkey
Acıbadem’s Grand Ambitions
There is perhaps no Turkish company in the healthcare sector that is more…
CEO Profile: Ferhat Farsi, CinnaGen İlaç
Dr Ferhat Farsi, CEO and founding partner of CinnaGen İlaç, shares his…
Read more from Turkey >>
Focus on Egypt
Striking the Access/Innovation Balance in Egyptian…
As Egypt rolls out Universal Health Insurance with the aim of achieving full…
GE Healthcare Egypt: Reimagining Care Provision
Amro Kandil, managing director Northeast Africa for GE Healthcare, outlines how…
Read more from Egypt >>
Focus on South Africa
Rare Diseases in South Africa: Bridging the Gap for…
Kelly du Plessis is CEO & Founder of Rare Diseases South Africa, a…
Medical Device Segment braced for change in South Africa
Trailing behind South Africa’s pharmaceutical market in both value and growth,…
Read more from South Africa >>
Focus on Algeria
Countering Algeria’s Diabetes Epidemic, With Pharmacists?
Yacine Sellam examines how pharmacists in Algeria can follow the lead of their…
European Solutions to Algeria’s Medicine Supply Shortages
Yacine Sellam, president of the Algerian Society for Regulatory Affairs &…
Read more from Algeria >>
Legal Q&As
Regulatory, Pricing and Reimbursement: South Africa
An insight into regulatory, pricing and reimbursement in South African Pharma. Prepared in association with Fasken,…
Cannabinoid Drugs and Medicinal Cannabis: South Africa
Structured legal guide to cannabinoid drugs, medicinal cannabis and opioid drugs in South Africa. Prepared in…
Preclinical and Clinical Trial Requirements: Egypt
Preclinical and clinical trial requirements in Egypt – an overview. Prepared in association with Youssry…
MEA / UAE to Boost Health Research Capabilities as Part of 50-Year Strategy
The United Arab Emirates’ Cabinet, the de facto executive branch of the federation, recently announced a set of…
Turkey’s Localisation Policy: From Consumption to Production
In 2016 the Turkish Medicine and Medical Devices Agency (TiTCK) implemented a localisation policy to reduce…
MEA / The UAE’s Fight Against Genetic Diseases
With a relatively high number of genetic disorders, the Arab population of the United Arab Emirates (UAE) is…
Israel’s Major Role in the Global Medical Cannabis Market
Saul Kaye of iCAN and CannaTech outlines a compelling case for Israel to be considered one of the world’s…
Pharma Faces / Paolo Carli, Merck MEAR
Paolo Carli, head of Middle East, Africa, Turkey, Russia and CIS (MEAR) for Merck has continually taken on greater…
Drug Shortage / European Solutions to Algeria’s Medicine Supply Shortages
Yacine Sellam, president of the Algerian Society for Regulatory Affairs & Pharmacoeconomics, looks at how…